PUBLISHER: Grand View Research | PRODUCT CODE: 2018181
PUBLISHER: Grand View Research | PRODUCT CODE: 2018181
The global ejection fraction market size was estimated at USD 6.3 billion in 2025 and is projected to reach USD 12.4 billion by 2033, growing at a CAGR of 8.0% from 2026 to 2033. The market is driven by the rising prevalence of heart failure and other cardiovascular diseases, which increase the need for regular and precise ejection fraction assessment.
Advances in non-invasive imaging technologies, such as AI-enabled echocardiography and cardiac MRI, are improving measurement accuracy and workflow efficiency. Growing adoption of remote monitoring solutions and integration with hospital information systems are enabling continuous patient management and early detection of cardiac deterioration, further developing the use of EF monitoring devices.
Global Ejection Fraction Market Report Segmentation
This report forecasts revenue growth and provides, at the global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global ejection fraction market report based on device type, technology, application, and region: